GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Connecticut grocery chain Stew Leonard's settled a decade-long lawsuit Wednesday over a depraved ex-employee swiping female coworkers' underwear just as the trial was about to kick off....
A Los Angeles-based band has suspended their “Waves” tour after their truck and all their equipment inside was stolen in Oakland ahead of a show at the UC Theatre in Berkeley....
Louisiana suspends House primaries amid Supreme Court ruling; GOP eyes redistricting gains in 2026 elections....
